2,440
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Histological and functional outcomes in a rat model of hemisected spinal cord with sustained VEGF/NT-3 release from tissue-engineered grafts

, , , &
Pages 362-376 | Received 29 Aug 2019, Accepted 03 Dec 2019, Published online: 03 Jan 2020

References

  • Lai BQ, Che MT, Du BL, et al. Transplantation of tissue engineering neural network and formation of neuronal relay into the transected rat spinal cord. Biomaterials. 2016;109:40–54.
  • Mautes AE, Weinzierl MR, Donovan F, et al. Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys Ther. 2000;80:673–687.
  • Wen Y, Yu S, Wu Y, et al. Spinal cord injury repair by implantation of structured hyaluronic acid scaffold with PLGA microspheres in the rat. Cell Tissue Res. 2016;364(1):17–28.
  • Popa C, Popa F, Grigorean VT, et al. Vascular dysfunctions following spinal cord injury. J Med Life. 2010;3(3):275–285.
  • Esposito E, Mazzon E, Paterniti I, et al. Olprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in mice. PLoS One. 2010;5(9):e12170.
  • Kundi S, Bicknell R, Ahmed Z. The role of angiogenic and wound-healing factors after spinal cord injury in mammals. Neurosci Res. 2013;76(1–2):1–9.
  • Hu JZ, Long H, Wu TD, et al. The effect of estrogen-related receptor alpha on the regulation of angiogenesis after spinal cord injury. Neuroscience. 2015;290:570–580.
  • Ruiz de Almodovar C, Lambrechts D, Mazzone M, et al. Role and therapeutic potential of VEGF in the nervous system. Phys Rev. 2009;89(2):607–648.
  • Xu ZX, Zhang LQ, Wang CS, et al. Acellular spinal cord scaffold implantation promotes vascular remodeling with sustained delivery of VEGF in a rat spinal cord hemisection model. Curr Neurovascular Res. 2017;14(3):274–289.
  • Johnson PJ, Tatara A, Shiu A, et al. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant. 2010;19(1):89–101.
  • Keefe KM, Sheikh IS, Smith GM. Targeting neurotrophins to specific populations of neurons: NGF, BDNF, and NT-3 and their relevance for treatment of spinal cord injury. Int J Mol Sci. 2017;18(3):548.
  • Bamber NI, Li H, Lu X, et al. Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur J Neurosci. 2001;13:257–268.
  • Brock JH, Rosenzweig ES, Blesch A, et al. Local and remote growth factor effects after primate spinal cord injury. J Neurosci. 2010;30(29):9728–9737.
  • McCall J, Weidner N, Blesch A. Neurotrophic factors in combinatorial approaches for spinal cord regeneration. Cell Tissue Res. 2012;349(1):27–37.
  • Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24(1):677–736.
  • Blum R, Konnerth A. Neurotrophin-mediated rapid signaling in the central nervous system: mechanisms and functions. Physiology (Bethesda, MD). 2005;20:70–78.
  • Blais M, Levesque P, Bellenfant S, et al. Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model. Tissue Eng A. 2013;19(15–16):1655–1664.
  • Su YW, Chung R, Ruan CS, et al. Neurotrophin-3 induces BMP-2 and VEGF activities and promotes the bony repair of injured growth plate cartilage and bone in rats. J Bone Miner Res. 2016;31(6):1258–1274.
  • Lee JY, Giusti G, Friedrich PF, et al. Effect of vascular endothelial growth factor administration on nerve regeneration after autologous nerve grafting. J Reconstr Microsurg. 2015;32(03):183–188.
  • Coumans JV, Lin TT, Dai HN, et al. Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. J Neurosci. 2001;21(23):9334–9344.
  • Koda M, Kamada T, Hashimoto M, et al. Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor to bone marrow stromal cells promotes axonal regeneration after transplantation in completely transected adult rat spinal cord. Eur Spine J. 2007;16:2206–2214.
  • Gunther MI, Weidner N, Muller R, et al. Cell-seeded alginate hydrogel scaffolds promote directed linear axonal regeneration in the injured rat spinal cord. Acta Biomater. 2015;27:140–150.
  • Li W, Lan Y, Guo R, et al. In vitro and in vivo evaluation of a novel collagen/cellulose nanocrystals scaffold for achieving the sustained release of basic fibroblast growth factor. J Biomater Appl. 2015;29(6):882–893.
  • Mohtaram NK, Montgomery A, Willerth SM. Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors. Biomed Mater. 2013;8(2):022001.
  • Li G, Che MT, Zhang K, et al. Graft of the NT-3 persistent delivery gelatin sponge scaffold promotes axon regeneration, attenuates inflammation, and induces cell migration in rat and canine with spinal cord injury. Biomaterials. 2016;83:233–248.
  • Han FY, Thurecht KJ, Whittaker AK, et al. Bioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loading. Front Pharmacol. 2016;7:185.
  • Guo SZ, Ren XJ, Wu B, et al. Preparation of the acellular scaffold of the spinal cord and the study of biocompatibility. Spinal Cord. 2010;48(7):576–581.
  • Chen J, Zhang Z, Liu J, et al. Acellular spinal cord scaffold seeded with bone marrow stromal cells protects tissue and promotes functional recovery in spinal cord-injured rats. J Neurosci Res. 2014;92(3):307–317.
  • Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61(4):364–370.
  • Qu J, Zhang H. Roles of mesenchymal stem cells in spinal cord injury. Stem Cells Int. 2017;2017:1–12.
  • Lin L, Lin H, Bai S, et al. Bone marrow mesenchymal stem cells (BMSCs) improved functional recovery of spinal cord injury partly by promoting axonal regeneration. Neurochem Int. 2018;115:80–84.
  • Nakano N, Nakai Y, Seo TB, et al. Characterization of conditioned medium of cultured bone marrow stromal cells. Neurosci Lett. 2010;483(1):57–61.
  • Herran E, Perez-Gonzalez R, Igartua M, et al. VEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer's disease. J Controlled Release. 2013;170:111–119.
  • Rui J, Dadsetan M, Runge MB, et al. Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: in vitro characterization and application in polycaprolactone fumarate nerve conduits. Acta Biomater. 2012;8(2):511–518.
  • Liu T, Xu J, Chan BP, et al. Sustained release of neurotrophin-3 and chondroitinase ABC from electrospun collagen nanofiber scaffold for spinal cord injury repair. J Biomed Mater Res. 2012;100:236–242.
  • Xu ZX, Li T, Zhong ZM, et al. Amide-linkage formed between ammonia plasma treated poly(D,L-lactide acid) scaffolds and bio-peptides: enhancement of cell adhesion and osteogenic differentiation in vitro. Biopolymers. 2011;95(10):682–694.
  • An Q, Wu D, Ma Y, et al. Suppression of evi1 promotes the osteogenic differentiation and inhibits the adipogenic differentiation of bone marrow-derived mesenchymal stem cells in vitro. Int J Mol Med. 2015;36(6):1615–1622.
  • Yu S, Yao S, Wen Y, et al. Angiogenic microspheres promote neural regeneration and motor function recovery after spinal cord injury in rats. Sci Rep. 2016;6(1):33428.
  • Gwak SJ, Yun Y, Yoon DH, et al. Therapeutic use of 3beta-[n-(n',n'-dimethylaminoethane) carbamoyl] cholesterol-modified PLGA nanospheres as gene delivery vehicles for spinal cord injury. PLoS One. 2016;11(1):e0147389.
  • Tang S, Liao X, Shi B, et al. The effects of controlled release of neurotrophin-3 from PCLA scaffolds on the survival and neuronal differentiation of transplanted neural stem cells in a rat spinal cord injury model. PLoS One. 2014;9(9):e107517.
  • Imperato-Kalmar EL, McKinney RA, Schnell L, et al. Local changes in vascular architecture following partial spinal cord lesion in the rat. Exp Neurol. 1997;145(2):322–328.
  • Figley SA, Liu Y, Karadimas SK, et al. Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury. PLoS One. 2014;9(5):e96137.
  • Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005;50(4):427–434.
  • Lutton C, Young YW, Williams R, et al. Combined VEGF and PDGF treatment reduces secondary degeneration after spinal cord injury. J Neurotrauma. 2012;29(5):957–970.